Boosting Host Immunity to Combat Coronavirus Disease-2019 (COVID-19)-Reference-Cited by-同舟云学术

Boosting Host Immunity to Combat Coronavirus Disease-2019 (COVID-19)

Published:2023-11-02 Issue: Volume: Page:166-199
ISSN:
Container-title:Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
language:
Short-container-title:

Author:

Rudrapal Mithun¹,Bhattacharya Soumya²,Chetia Dipak³

Affiliation:

1. Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan’s Foundation for Science, Technology & Research, Guntur, India

2. Guru Nanak Institute of Pharmaceutical Science and Technology, 157/F Nilgunj Road, Panihati, Kolkata, India

3. Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh 786004, Assam, India

Abstract

Despite significant efforts in drug discovery and development, combating Coronavirus Disease (COVID-19) still remains to be an increasingly challenging health problem because of the fact that the recommended current therapies are intended only for the symptomatic treatment and/or prophylaxis of SARS-CoV-2 infections/COVID 19 patients, but do not cure the disease. In this context, several complementary and alternative, but potential healthcare practices (CAMs) that could effectively boost host immunity are firmly believed to be one of the major medical interventions for the prevention as well as control of COVID-19. In this review, several immunity-boosting measures based upon traditional healthcare practices including traditional herbal remedies, home remedies, and alternative and complementary therapies including yoga and naturopathies to fight against SARS-CoV-2 infections/ COVID-19 have been reviewed

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference135 articles.

1. Pal M.; Berhanu G.; Desalegn C.; Kandi V.; Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An update. Cureus 2020 ,12(3),e7423

2. V’kovski P.; Kratzel A.; Steiner S.; Stalder H.; Thiel V.; Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 2021 ,19(3),155-170

3. Zhu Z.; Lian X.; Su X.; Wu W.; Marraro G.A.; Zeng Y.; From SARS and MERS to COVID-19: A brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020 ,21(1),224

4. Abdelrahman Z.; Li M.; Wang X.; Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory virus. Front Immunol 2020 ,11,552909

5. Cooper EL; Commentary on CAM and NK cells by kazuyoshi takeda and ko okumura. eCAM 2004 ,1,29-34